Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

BACKGROUND: FibroTest and elastography have been validated as biomarkers of liver fibrosis in the most frequent chronic liver diseases and in the fibrosis screening of patients with diabetes. One challenge was to use them for estimating the prevalence of fibrosis, identifying independent risk factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Poynard, Thierry, Lebray, Pascal, Ingiliz, Patrick, Varaut, Anne, Varsat, Brigitte, Ngo, Yen, Norha, Pascal, Munteanu, Mona, Drane, Fabienne, Messous, Djamila, Bismut, Françoise Imbert, Carrau, Jean Pierre, Massard, Julien, Ratziu, Vlad, Giordanella, Jean Pierre
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864202/
https://www.ncbi.nlm.nih.gov/pubmed/20412588
http://dx.doi.org/10.1186/1471-230X-10-40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864202/
https://www.ncbi.nlm.nih.gov/pubmed/20412588
http://dx.doi.org/10.1186/1471-230X-10-40

Ejemplares similares